Anti-IgE Treatment with Oral Immunotherapy in Multifood Allergic Participants: Results of a Randomized, Double-blinded Control Trial

BACKGROUND: Despite progress in single food oral immunotherapy (OIT), there is little evidence concerning the safety and efficacy of treating individuals with multiple food (multifood) allergies. We conducted a pilot study testing whether anti-IgE (omalizumab) combined with multifood OIT benefitted...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Lancet Gastroenterol Hepatol
Glavni autori: Andorf, Sandra, Purington, Natasha, Block, Whitney M., Long, Andrew J., Tupa, Dana, Brittain, Erica, Spergel, Amanda Rudman, Desai, Manisha, Galli, Stephen J., Nadeau, Kari C., Chinthrajah, R. Sharon
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944204/
https://ncbi.nlm.nih.gov/pubmed/29242014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(17)30392-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items